Arthrosurface received FDA 510(k) clearance to market the BOS’s Toe Fixation system for patients who want to avoid joint fusion and return to an active lifestyle.
BOSS is intended to improve stabilization in a first metatarsal that presents with a distal bone void, and provides patients with a motion-preserving alternative to fusion.
The device is used with Arthrosurface’s existing HemiCAP DF® implants and ToeMotionâ„¢ systems, offering immediate rigid fixation in cases with metaphyseal bone loss. It is designed to stabilize the joint while maintaining the length and mechanical axis of the toe.
Arthrosurface received FDA 510(k) clearance to market the BOS's Toe Fixation system for patients who want to avoid joint fusion and return to an active lifestyle.
BOSS is intended to improve stabilization in a first metatarsal that presents with a distal bone void, and provides patients with a motion-preserving alternative to fusion.
The...
Arthrosurface received FDA 510(k) clearance to market the BOS’s Toe Fixation system for patients who want to avoid joint fusion and return to an active lifestyle.
BOSS is intended to improve stabilization in a first metatarsal that presents with a distal bone void, and provides patients with a motion-preserving alternative to fusion.
The device is used with Arthrosurface’s existing HemiCAP DF® implants and ToeMotionâ„¢ systems, offering immediate rigid fixation in cases with metaphyseal bone loss. It is designed to stabilize the joint while maintaining the length and mechanical axis of the toe.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
